Abbott Laboratories' micronized fenofibrate (TriCor) capsules have been approved for the treatment of patients with Frederickson Type Ia and Ilb hyperlipoproteinemia.
Micronized fenofibrate is approved as adjunctive therapy to diet for the reduction of low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Frederickson Types IIa and IIb).
Copyright Springhouse Corporation Aug 2000
Provided by ProQuest Information and Learning Company. All rights Reserved